Organigram (TSE:OGI) Reaches New 1-Year Low - Should You Sell?

Organigram Holdings Inc. (TSE:OGI - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as C$1.65 and last traded at C$1.66, with a volume of 112769 shares traded. The stock had previously closed at C$1.66.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on OGI. ATB Capital lowered their target price on Organigram from C$5.25 to C$3.50 in a research report on Tuesday, December 17th. Canaccord Genuity Group lowered their target price on Organigram from C$3.60 to C$3.15 and set a "speculative buy" rating for the company in a research report on Monday, December 9th.

Organigram Stock Performance

The company has a debt-to-equity ratio of 3.07, a quick ratio of 2.62 and a current ratio of 3.36. The stock has a fifty day simple moving average of C$2.13 and a two-hundred day simple moving average of C$2.28. The stock has a market capitalization of C$191.49 million, a price-to-earnings ratio of -3.28, a P/E/G ratio of 0.42 and a beta of 1.13.

Organigram Company Profile

Organigram Inc is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.